Leukemia, B-Cell  >>  Valcyte (valganciclovir)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Valcyte (valganciclovir) / Roche, Mitsubishi Tanabe
VGCV-CLL, NCT01255644 / 2010-021786-78: Antiviral Treatment of Chronic Lymphocytic Leukemia

Completed
4
20
Europe
Valganciclovir, Valcyte
Medical University of Vienna
Chronic Lymphocytic Leukemia
07/15
07/15

Download Options